Epstein-Barr virus latent membrane protein 2A (LMP2A) induces many characteristics of carcinoma, including transformation, migration, invasion, and impaired differentiation. The MCF10A cell line differentiates to form hollow acini when grown in Matrigel, and expression of LMP2A inhibited differentiation and anoikis induced by loss of matrix attachment. LMP2A-infected cells formed large, lobular structures rather than hollow acini. Autophagy inhibitors impaired this abnormal growth and induced caspase 3 activation and acinus formation. LMP2A also increased autophagosome formation and expression of proteins in the autophagosome pathway. These findings suggest that LMP2A may inhibit anoikis and luminal clearance in acini through induction of autophagy. E pstein-Barr virus (EBV) latent membrane protein 2A (LMP2A) is consistently detected at the RNA and protein levels in the epithelial cancer nasopharyngeal carcinoma (1-4). LMP2A has been shown to impair differentiation and induce migration, which likely contributes to the development of epithelial cancers. Human MCF10A cells are nonmalignant breast epithelial cells that undergo distinct differentiation when grown in three-dimensional culture and form spherical acini with a characteristic hollow lumen. Many oncogenes affect this process and block acinus formation, a process that is dependent on anoikis or apoptosis induced by lack of attachment to the extracellular matrix. Previously, LMP2A has been shown to block anoikis in MCF10A cells and to induce the formation of large, irregular growths with a filled lumen (5). The N-terminal src binding domain and the sycbinding immunoreceptor tyrosine-based activation motif were required for inhibition of anoikis (5). In contrast, mutation of the PY domain known to bind NEDD4 ubiquitin ligases, including Itch, did not block anoikis but rather resulted in the formation of acini that were hollow, spherical, and larger than those formed in control cells. This finding suggested that PY interactions with NEDD4-like ubiquitin ligases are important for impairment of anoikis (5).
Epstein-Barr virus latent membrane protein 2A (LMP2A) induces many characteristics of carcinoma, including transformation, migration, invasion, and impaired differentiation. The MCF10A cell line differentiates to form hollow acini when grown in Matrigel, and expression of LMP2A inhibited differentiation and anoikis induced by loss of matrix attachment. LMP2A-infected cells formed large, lobular structures rather than hollow acini. Autophagy inhibitors impaired this abnormal growth and induced caspase 3 activation and acinus formation. LMP2A also increased autophagosome formation and expression of proteins in the autophagosome pathway. These findings suggest that LMP2A may inhibit anoikis and luminal clearance in acini through induction of autophagy. E pstein-Barr virus (EBV) latent membrane protein 2A (LMP2A) is consistently detected at the RNA and protein levels in the epithelial cancer nasopharyngeal carcinoma (1) (2) (3) (4) . LMP2A has been shown to impair differentiation and induce migration, which likely contributes to the development of epithelial cancers. Human MCF10A cells are nonmalignant breast epithelial cells that undergo distinct differentiation when grown in three-dimensional culture and form spherical acini with a characteristic hollow lumen. Many oncogenes affect this process and block acinus formation, a process that is dependent on anoikis or apoptosis induced by lack of attachment to the extracellular matrix. Previously, LMP2A has been shown to block anoikis in MCF10A cells and to induce the formation of large, irregular growths with a filled lumen (5) . The N-terminal src binding domain and the sycbinding immunoreceptor tyrosine-based activation motif were required for inhibition of anoikis (5) . In contrast, mutation of the PY domain known to bind NEDD4 ubiquitin ligases, including Itch, did not block anoikis but rather resulted in the formation of acini that were hollow, spherical, and larger than those formed in control cells. This finding suggested that PY interactions with NEDD4-like ubiquitin ligases are important for impairment of anoikis (5) .
Autophagy is a process that provides energy conservation to cells undergoing stress and is thought to inhibit anoikis by prolonging cell viability until matrix reattachment occurs (6) (7) (8) (9) (10) (11) . Interestingly, a high-throughput screen for ubiquitin ligase inhibitors recently identified clomipramine as an inhibitor of Itch and identified a role for Itch in the regulation of autophagy (12) . To test the hypothesis that LMP2A blocked anoikis through induction of autophagy, MCF10A cell lines that contained the pBabe vector control or expressed wild-type LMP2A were established. The LMP2A expression levels were comparable to those of the Jijoye lymphocyte line (Fig. 1A) . The cells were seeded in threedimensional culture to induce acinus formation in the presence of autophagy inhibitors. Treatment with the type III phosphoinositol 3-kinase inhibitor 3-methyladenine (3-MA; 10 mM, days 6 to 8), which blocks the activation of the autophagosome (AP) initiation complex, induced increased cleaved caspase 3 in the LMP2A spheres with evidence of luminal clearing, suggesting that the autophagy initiation complex is required for resistance to anoikis and impaired lumen formation (Fig. 1B) . Some of the LMP2A-expressing cells within the lumen remained positive for staining with Ki67 as an indicator of DNA synthesis. Treatment of LMP2A acini with the late-stage autophagy inhibitor chloroquine (CQ; 30 g/ml) also induced luminal clearing and significantly higher levels of cleaved caspase 3 (Fig. 1B) . Treatment with either inhibitor did not affect the formation of acini in vector control cells.
Treatment of acini with CQ blocks autophagy through inhibition of enzymes that require an acidic environment. Thus, CQ treatment prevents the degradation of AP components and stabilizes APs. APs can be identified by the binding of LC3II, which is produced by lipidation of LC3 in a process that resembles ubiquitination. Treatment with CQ induces AP accumulation and enables the detection of immunofluorescent LC3II. LMP2A MCF10A cells treated with dimethyl sulfoxide (DMSO) during growth in Matrigel (days 6 to 8) formed characteristic multilobular structures, whereas CQ treatment inhibited autophagy, resulting in spherical acini, some evidence of hollowing, and significantly increased detection of LC3II, indicating that autophagy had been activated by LMP2A (Fig. 1C) .
To determine when LMP2A induced autophagy, APs were detected with a stain specific for APs (Enzo Life Sciences Cyto-ID staining kit) in vector control and LMP2A-expressing MCF10A cells from day 5 to day 23 during growth in Matrigel (Fig. 2) . Positive staining for APs was detected in LMP2A acini at low levels by day 8, with strong detection on days 10 and 17. In contrast, pBabe acini had low AP levels detectable only on day 10. These findings indicate that LMP2A produced AP formation greater than that in vector control cells.
To test the hypothesis that LMP2A induced autophagy to promote anoikis resistance following detachment, pBabe vector control and wild-type LMP2A-and PY mutant LMP2A-expressing MCF10A cells were cultured for 24 h in dishes coated with poly(2-hydroxyethyl methacrylate) (polyHEMA) at 10 mg/ml with or without CQ treatment. After 24 h, suspension cells were stained with the Cyto-ID staining to kit to label APs. Hoechst 33342 nuclear staining indicated that LMP2A-expressing cells formed large clumps when cultured on HEMA plates, in contrast to single cells in the pBabe vector control or small colonies formed by PY mutant cells (Fig. 3) . Trace levels of APs were detected in pBabe vector control cells, with higher AP levels in LMP2A-and PY-expressing cells. Treatment with CQ enhanced AP detection. These findings reveal that LMP2A induced AP formation but this induction did not require the PY domain (Fig. 3) .
To confirm AP formation in HEMA cultures, whole-cell lysates were analyzed by immunoblotting 24 h after seeding (Fig. 4A) . Slightly lower levels of cleaved poly(ADP-ribose) polymerase 1 (PARP), as an indicator of cell death, were detected in LMP2A-expressing cells than in pBabe vector control cells. LMP2A-expressing cells also had slightly greater expression of Atg7, which is activated early in the induction of autophagy. LC3B expression was increased in LMP2A-expressing cells, and treatment with protease inhibitors enhanced its detection (Fig. 4A) . To further assess the activation of autophagy, the formation of the Atg5/Atg12 E3-like ligase complex, which is required for LC3 lipidation, was assessed by determining the association of Atg5 with Atg12. Immunoprecipitation of Atg5 from whole-cell lysates, followed by Western blotting for Atg12, indicated increased complex formation in LMP2A-expressing cells, while the levels in PY mutant LMP2A-expressing cells were comparable to those in vector control cells (Fig. 4B) . These data indicate that following matrix detachment, LMP2A increases the expression of AP proteins and the formation of ATG complexes.
These findings reveal that inhibition of autophagy impaired LMP2A-mediated anoikis resistance in MCF10A cells, resulting in the formation of hollow lumens and the activation of caspase 3. Additionally, induction of detachment-induced cell death follow- ing culture on polyHEMA-coated culture plates revealed that LMP2A increased the expression of proteins required for AP formation, including the formation of the Atg5/Atg12 complex and LC3. These findings indicate that by increasing the expression of proteins required for AP formation, LMP2A increases autophagy to maintain viability after loss of matrix attachment. The LMP2A-mediated induction of autophagy in detached luminal cells likely contributes to the impaired development of acini and indicates that LMP2A uses autophagy to evade anoikis. Enhanced autophagy is likely a critical factor in the inhibition of acinus formation and continued growth of luminal cells induced by LMP2A (6) . Evasion of anoikis is thought to be a critical ability for the metastasis of malignant cells. The ability of LMP2A to induce migration is also thought to potentially contribute to metastasis. Thus, the properties of LMP2A that inhibit differentiation, induce migration, and block anoikis through induction of autophagy are likely to be critical to the contribution of LMP2A to the metastasis of EBV-positive carcinomas.
